1. Home
  2. SVRA vs ANDG Comparison

SVRA vs ANDG Comparison

Compare SVRA & ANDG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Savara Inc.

SVRA

Savara Inc.

N/A

Current Price

$4.90

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Logo Andersen Group Inc. Class A Common Stock

ANDG

Andersen Group Inc. Class A Common Stock

N/A

Current Price

$66.42

Market Cap

1.3B

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
SVRA
ANDG
Founded
2007
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.3B
IPO Year
2009
2025

Fundamental Metrics

Financial Performance
Metric
SVRA
ANDG
Price
$4.90
$66.42
Analyst Decision
Strong Buy
Buy
Analyst Count
9
8
Target Price
$11.06
★ $61.29
AVG Volume (30 Days)
★ 2.7M
411.5K
Earning Date
11-24-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $838,692,000.00
Revenue This Year
N/A
$18.38
Revenue Next Year
$9,266.31
$18.35
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 14.64
52 Week Low
$4.13
$18.12
52 Week High
$7.01
$68.41

Technical Indicators

Market Signals
Indicator
SVRA
ANDG
Relative Strength Index (RSI) 49.75 68.09
Support Level $4.73 $52.10
Resistance Level $5.47 $68.41
Average True Range (ATR) 0.32 2.53
MACD 0.04 -0.13
Stochastic Oscillator 61.07 76.52

Price Performance

Historical Comparison
SVRA
ANDG

About SVRA Savara Inc.

Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).

About ANDG Andersen Group Inc. Class A Common Stock

Andersen Group Inc is a provider of independent tax, valuation, and financial advisory services to individuals and family offices, businesses, and institutional clients in the United States. It has strategically expanded its business to build an integrated platform of service offerings that enables the company to solve its clients' complex tax and financial challenges. The company's end-to-end services offerings include: Private Client Services, Business Tax Services, Alternative Investment Funds, and Valuation Services. The firm generates the key revenue from Private Client Services, which provide comprehensive tax and financial services for individuals and families, addressing complex client matters involving multigenerational wealth, charitable giving, and trust and estate planning.

Share on Social Networks: